Riikka Havunen
Company: TILT Biotherapeutics
Job title: Head of Research And Development
Seminars:
Clinical TIL Treatment: Addressing the Combination, Order & Impact of Therapeutic Approaches Q&A + Open Counsel 12:30 pm
day: Conference Day
TILT -123 in Phase 1 Clinical Trials. Concurrent TIL & Oncolytic Viral Therapy. 11:40 am
Interpreting current clinical evidence and extrapolating the benefits Describing mechanistic action of oncolytic virus Considering changes in the tumor microenvironment and TIL response from viral treatmentRead more
day: Conference Day